Seres therapeutics to participate in h.c. wainwright 27th annual global investment conference

Cambridge, mass., aug. 27, 2025 (globe newswire) -- seres therapeutics, inc. (nasdaq: mcrb), a leading live biotherapeutics company, today announced that management will attend the upcoming h.c. wainwright global investment conference in new york city and will present a company overview at 3:00 p.m. et on september 8, 2025.
MCRB Ratings Summary
MCRB Quant Ranking